DGAT1 inhibition for treatment of demyelinating inflammatory disease

Methods are provided for treating autoimmune disease in a subject by inhibiting the activity of DGAT1.

Saved in:
Bibliographic Details
Format Patent
LanguageEnglish
Published 12.03.2019
Online AccessGet full text

Cover

Loading…
More Information
Summary:Methods are provided for treating autoimmune disease in a subject by inhibiting the activity of DGAT1.